Literature DB >> 22640846

Bronchiectasis and nontuberculous mycobacterial disease.

David E Griffith1, Timothy R Aksamit.   

Abstract

Over the last 30 years it has become increasingly clear that nontuberculous mycobacterial (NTM) lung infections and bronchiectasis are closely related disorders. Although incontrovertible proof is lacking, there is a growing consensus of opinion that NTM lung disease characterized by nodules and bronchiectasis (nodular/bronchiectatic NTM lung disease) may be a consequence of preexisting bronchiectasis that predisposes to NTM infection and disease. To use published diagnostic guidelines effectively, physicians must become familiar with the disease-causing potential of individual NTM species. Essentially all NTM patients have bronchiectasis, so optimal overall patient management requires successful therapeutic strategies for both NTM infection and bronchiectasis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22640846     DOI: 10.1016/j.ccm.2012.02.002

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  22 in total

Review 1.  Surgical management of non-cystic fibrosis bronchiectasis.

Authors:  Miyako Hiramatsu; Yuji Shiraishi
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

2.  Diminished Susceptibility of African-Americans to Non-tuberculous Mycobacterial Disease.

Authors:  Jerome M Reich; Jong S Kim
Journal:  Lung       Date:  2017-11-13       Impact factor: 2.584

Review 3.  Nontuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis.

Authors:  In Kwon Park; Kenneth N Olivier
Journal:  Semin Respir Crit Care Med       Date:  2015-03-31       Impact factor: 3.119

Review 4.  Lung Disease in Primary Antibody Deficiencies.

Authors:  Edith Schussler; Mary B Beasley; Paul J Maglione
Journal:  J Allergy Clin Immunol Pract       Date:  2016 Nov - Dec

5.  Protein-coding housekeeping gene Rv2461c can be used as an amplification target in loop-mediated isothermal amplification assay for the detection of Mycobacterium tuberculosis in sputum samples.

Authors:  Dairong Li; Jianing Zhao; Xiaoping Nie; Tao Wan; Wenchun Xu; Yong Zhao
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

Review 6.  Chronic Lung Disease in Primary Antibody Deficiency: Diagnosis and Management.

Authors:  Paul J Maglione
Journal:  Immunol Allergy Clin North Am       Date:  2020-06-09       Impact factor: 3.479

7.  Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease.

Authors:  Kelly M Pennington; Ann Vu; Douglas Challener; Christina G Rivera; F N U Shweta; John D Zeuli; Zelalem Temesgen
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-05-08

Review 8.  Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis.

Authors:  Giulia Bonaiti; Alberto Pesci; Almerico Marruchella; Giuseppe Lapadula; Andrea Gori; Stefano Aliberti
Journal:  Biomed Res Int       Date:  2015-05-27       Impact factor: 3.411

Review 9.  Understanding nontuberculous mycobacterial lung disease: it's been a long time coming.

Authors:  David E Griffith; Timothy R Aksamit
Journal:  F1000Res       Date:  2016-11-30

10.  Factors associated with lung function decline in patients with non-tuberculous mycobacterial pulmonary disease.

Authors:  Meng-Rui Lee; Ching-Yao Yang; Kai-Ping Chang; Li-Ta Keng; David Hung-Tsang Yen; Jann-Yuan Wang; Huey-Dong Wu; Li-Na Lee; Chong-Jen Yu
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.